IUHSA
EGRX

Itau Unibanco Holding S.A.’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,495
Closed -$69K – 454
2020
Q1 		$69K Sell
1,495
-747
-33% -$37.5K 0.01% 181
2019
Q4 		$135K Buy
+2,242
New +$134K 0.01% 407
2018
Q4 		– Sell
-1,562
Closed -$108K – 694
2018
Q3 		$108K Buy
1,562
+128
+9% +$9.7K 0.01% 471
2018
Q2 		$108K Buy
+1,434
New +$90.2K 0.01% 523

Other funds holding EGRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Itau Unibanco Holding S.A.'s EGRX Position: Q2 2020 in Review

Itau Unibanco Holding S.A. sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2020, closing a stake of 1,495 shares — an estimated $69K sold.

Itau Unibanco Holding S.A. first reported a position in EGRX in Q2 2018 and held it in 4 quarters. The position peaked at $135K in Q4 2019. 164 funds tracked by Wall St. Rank hold EGRX as of Q2 2020.

  • Itau Unibanco Holding S.A. reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 1,495 Eagle Pharmaceuticals, Inc. shares in Q2 2020, an estimated $69K.
  • Itau Unibanco Holding S.A. first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2018 and held it in 4 quarters.
  • Itau Unibanco Holding S.A.'s Eagle Pharmaceuticals, Inc. position peaked at $135K in Q4 2019.
  • 164 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2020.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2020, filed 14 Aug 2020.